FDA approves first drug comprised of an active ingredient derived from marijuana to treat epilepsy

One 6/25/18 the FDA approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age or older. The significance of this approval is that it is the first FDA-approved drug that contains a drug substance derived from marijuana. CBD is a chemical component of the … Continue reading FDA approves first drug comprised of an active ingredient derived from marijuana to treat epilepsy